Elevai Labs Past Earnings Performance
Past criteria checks 0/6
Elevai Labs's earnings have been declining at an average annual rate of -57.6%, while the Personal Products industry saw earnings growing at 10.2% annually. Revenues have been growing at an average rate of 68.5% per year.
Key information
-57.6%
Earnings growth rate
-51.8%
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | 68.5% |
| Return on equity | -112.4% |
| Net Margin | -251.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Elevai Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -4 | 4 | 0 |
| 30 Sep 23 | 1 | -4 | 4 | 0 |
| 30 Jun 23 | 1 | -4 | 3 | 0 |
| 31 Mar 23 | 1 | -3 | 2 | 0 |
| 31 Dec 22 | 1 | -2 | 2 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
Quality Earnings: ELAB is currently unprofitable.
Growing Profit Margin: ELAB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ELAB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ELAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ELAB is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (0.2%).
Return on Equity
High ROE: ELAB has a negative Return on Equity (-112.4%), as it is currently unprofitable.